| NDC Code | 54868-6360-0 |
|---|
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (54868-6360-0) |
|---|
| Product NDC | 54868-6360 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Complera |
|---|
| Non-Proprietary Name | Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20130201 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA202123 |
|---|
| Manufacturer | Physicians Total Care, Inc. |
|---|
| Substance Name | EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE |
|---|
| Strength | 200; 25; 300 |
|---|
| Strength Unit | mg/1; mg/1; mg/1 |
|---|
| Pharmacy Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Non-Nucleoside Analog [Chemical/Ingredient],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
|---|